HealthLeaders Media April 27, 2022
The bills aim to speed the discovery of new cures, improve patient representation in clinical trials, and enhance the FDA’s ability to ensure safety, efficacy, and quality of the drug supply.
KEY TAKEAWAYS
– A House subcommittee is taking up 22 bills that tackle different areas in healthcare, particularly in pharma, that need major legislative change.
– The mostly bipartisan bills aim to speed the discovery of new cures, improve patient representation in clinical trials and enhance the FDA’s ability to fulfill its mission of ensuring the safety, efficacy, and quality of the drug supply.
– Industry trade associations BIO, PhRMA, and the Association for Accessible Medicines (AAM) each provided testimony during the recent hearing in support of certain...